Ad
related to: can genetic testing affect insurance coverage
Search results
Results from the WOW.Com Content Network
Medicare may provide coverage for genetic testing when it is medically necessary for a diagnosis or treatment. ... The costs of genetic tests can vary and may be between $100 and $2,000 without ...
The benefits can be substantial, but so can the risks. The possible adverse consequences of genetic tests include discrimination in employment and health insurance and breaches of privacy. Government policies are therefore needed to assure the proper use of genetic tests. The first piece of federal legislation came into effect in 2000.
Genetic testing is often done as part of a genetic consultation and as of mid-2008 there were more than 1,200 clinically applicable genetic tests available. [23] Once a person decides to proceed with genetic testing, a medical geneticist, genetic counselor, primary care doctor, or specialist can order the test after obtaining informed consent .
Accordingly, one effect of the legislation is to prohibit insurance providers from demanding that a prospective client undergo a genetic test—or to disclose an existing test—as a prerequisite to the provision of insurance coverage. The Genetic Non-Discrimination Act was opposed by the insurance industry and, upon its passage, then-attorney ...
Patients are typically offered testing if they have either a personal or family history of cancer that meets certain criteria, Zakalik adds. Those criteria have broadened over the last few years ...
The headline of an article I read said that genetic testing fraud could be the next big concern for U.S. healthcare. Considering that one lab owner was sentenced last year to 27 years in prison ...
While GINA has been cited as a strong step forward, some say that the legislation does not go far enough in enabling personal control over genetic testing results. [21] The law does not cover life, disability, or long-term care insurance, which may cause some reluctance to get tested. [20] [22]
Stephens initiated coverage on Myriad Genetics Inc (NASDAQ: MYGN) with an Equal-Weight rating and a price target of $22. The analyst writes that the company has been at the forefront of genetic ...
Ad
related to: can genetic testing affect insurance coverage